Form 8-K - Current report:
SEC Accession No. 0001096906-23-000428
Filing Date
2023-02-22
Accepted
2023-02-22 10:15:20
Documents
15
Period of Report
2023-02-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 8-K SEC FILING tpia-20230216.htm   iXBRL 8-K 19384
2 TERMINATION OF AGREEMENT AND PLAN OF MERGER tpia_ex10z1.htm EX-10.1 35878
3 PRESS RELEASE ANNOUNCING TERMINATION OF AGREEMENT AND PLAN OF MERGER tpia_ex99z1.htm EX-99.1 8684
  Complete submission text file 0001096906-23-000428.txt   205085

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20230216_def.xml EX-101.DEF 1809
5 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20230216_lab.xml EX-101.LAB 20731
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20230216_pre.xml EX-101.PRE 13739
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20230216.xsd EX-101.SCH 2480
9 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20230216_htm.xml XML 2427
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56022 | Film No.: 23650963
SIC: 2833 Medicinal Chemicals & Botanical Products